EYEGNasdaqinactive
KIORA PHARMACEUTICALS INC
Healthcare·Healthcare·CEO: Brian M. Strem, Ph.D.
Market Cap
$132.8M
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Go deeper on KIORA PHARMACEUTICALS INC with Spotter
Ask follow-up questions and run a full multi-agent deep dive on EYEG — live, with citations.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
5
Total value held
$22.5M
| Holder | Shares | Value |
|---|---|---|
| alliancebernstein l.p. | 473,000 | $16.9M |
| wealth enhancement advisory services, llc | 106,690 | $3.8M |
| citadel advisors llc | 37,168 | $1.3M |
| jane street group, llc | 13,440 | $475K |
| ubs group ag | 1 | $35 |
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on KIORA PHARMACEUTICALS INC
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.